Oral contraceptive plus spironolactone safely addresses androgen excess in PCOS

18 Sept 2017


PCOS women treated with a combination oral contraceptive with spironolactone were not at increased risk for metabolic or cardiovascular complications, according to findings published in the European Journal of Endocrinology.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story